Search research articles
Contact Us
Filters
Showing results (71-80 of 218) with videos related to
Page
of 22
Sort By:
Annals of Hematology
|
January 20, 1998
Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL)
J Braess, K Reich, S Willert, et al.
The British Journal of Dermatology
|
March 13, 2014
Ulcerative keratitis in psoriasis: a rare variant of psoriatic ocular inflammatory disease
V G Herbert, B Lögering, V von Gruben, et al.
Current Topics in Microbiology and Immunology
|
January 1, 1991
Phenotypic and functional characterization of human TCR gamma delta+ intestinal intraepithelial lymphocytes
K Deusch, K Pfeffer, K Reich, et al.
Dermatology (Basel, Switzerland)
|
February 18, 2006
Cost of moderate to severe plaque psoriasis in Germany: a multicenter cost-of-illness study
S Sohn, O Schoeffski, J Prinz, et al.
The Journal of Investigative Dermatology
|
October 3, 1999
Expression of the CD4+ cell-specific chemoattractant interleukin-16 in mycosis fungoides
V Blaschke, K Reich, P Middel, et al.
Zeitschrift Fur Rheumatologie
|
June 29, 2006
[Evidence-based therapy of Raynaud's syndrome]
M Distler, J Distler, A Ciurea, et al.
The American Journal of Emergency Medicine
|
October 17, 2022
Intravenous metoprolol versus diltiazem for atrial fibrillation with concomitant heart failure
Chad T Compagner, Caitlin R Wysocki, Emily K Reich, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
September 24, 2014
[Psoriasis-associated keratitis: case report]
F S Filev, V G Herbert, B Lögering, et al.
Infection and Immunity
|
December 1, 1991
Production and characterization of neutralizing and nonneutralizing monoclonal antibodies against listeriolysin O
F Nato, K Reich, S Lhopital, et al.
The British Journal of Dermatology
|
April 30, 2013
Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2)
K Reich, G Wozel, H Zheng, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 218) with videos related to
Sort By:
Page
of 22
Annals of Hematology
|
January 20, 1998
Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL)
J Braess, K Reich, S Willert, et al.
The British Journal of Dermatology
|
March 13, 2014
Ulcerative keratitis in psoriasis: a rare variant of psoriatic ocular inflammatory disease
V G Herbert, B Lögering, V von Gruben, et al.
Current Topics in Microbiology and Immunology
|
January 1, 1991
Phenotypic and functional characterization of human TCR gamma delta+ intestinal intraepithelial lymphocytes
K Deusch, K Pfeffer, K Reich, et al.
Dermatology (Basel, Switzerland)
|
February 18, 2006
Cost of moderate to severe plaque psoriasis in Germany: a multicenter cost-of-illness study
S Sohn, O Schoeffski, J Prinz, et al.
The Journal of Investigative Dermatology
|
October 3, 1999
Expression of the CD4+ cell-specific chemoattractant interleukin-16 in mycosis fungoides
V Blaschke, K Reich, P Middel, et al.
Zeitschrift Fur Rheumatologie
|
June 29, 2006
[Evidence-based therapy of Raynaud's syndrome]
M Distler, J Distler, A Ciurea, et al.
The American Journal of Emergency Medicine
|
October 17, 2022
Intravenous metoprolol versus diltiazem for atrial fibrillation with concomitant heart failure
Chad T Compagner, Caitlin R Wysocki, Emily K Reich, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
September 24, 2014
[Psoriasis-associated keratitis: case report]
F S Filev, V G Herbert, B Lögering, et al.
Infection and Immunity
|
December 1, 1991
Production and characterization of neutralizing and nonneutralizing monoclonal antibodies against listeriolysin O
F Nato, K Reich, S Lhopital, et al.
The British Journal of Dermatology
|
April 30, 2013
Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2)
K Reich, G Wozel, H Zheng, et al.
Page
of 22